Skip to main content

Table 1 Characteristics of Subjects recruited

From: LMA® protector™ in patients undergoing laparoscopic surgeries: a multicenter prospective observational study

Parameters

Successful cases (n = 290)

Failed cases (n = 10)

P value

Age (years)

43.78 ± 12.74

48.10 ± 11.93

0.2917

Male/Female, n

72/218

1/9

0.4603

Body weight (kg)

62.39 ± 10.76

58.35 ± 8.11

0.2409

Body mass index (kg m−2)

23.46 ± 3.32

22.75 ± 3.41

0.5070

ASA status, n (%)

  

0.8467

Class 1

136 (46.9%)

5 (50%)

 

Class 2

154 (53.1%)

5 (50%)

 

Mallampati Classification, n(%)

  

0.3896

1

135 (46.55%)

3 (30%)

 

2

142 (48.97%)

7 (70%)

 

3

13 (4.48%)

0

 

Type of Surgery, n (%)

  

0.7955

Gallbladder surgery

94 (32.41%)

3 (30%)

 

Gynecology

147 (50.69%)

6 (60%)

 

General surgery

49 (16.9%)

1 (10%)

 

Position of the patients, n (%)

  

0.9632

Supine position

23 (7.93%)

1 (10%)

 

Reverse-Trendelenburg position

95 (32.76%)

3 (30%)

 

Trendelenburg position

172 (59.31%)

6 (60%)

 

Duration of Surgery (min)

81.14 ± 41.30

 

Total dosage of neuromuscular blockade (mg)

  

0.8840

Rocuronium

48.62 ± 13.26

48.33 ± 16.02

 

Cisatracurium

14.82 ± 5.17

13.5 ± 1.66

 
  1. Data presented as mean (SD) or absolute numbers (%). ASA American Society of Anesthesiologists